Key Takeaways
- Regulatory watershed ahead: Industry lawyers predict 2026 could be the most significant regulatory year for dietary supplements since GMPs were introduced, with the FDA planning to close the self-GRAS loophole and finalise NDI guidance.
- M&A activity accelerates: PK Consumer Health acquired UK-based HealthAid to build a European VMS platform, while Monterey Bay Herb Co. expanded its nutraceutical footprint by acquiring NP Nutra.
- Mushroom-derived supplement boosts vaccine response: A UC San Diego clinical trial found that a dual-mycelium blend of Agarikon and Turkey Tail reduced COVID-19 vaccine side effects and potentially tripled antibody levels for up to six months.
- EU customs crackdown on non-compliant supplements: A large-scale EU customs operation found that the majority of food supplements sold online from outside the EU fail to meet regulatory standards.
- North American supplement market projected to reach $175.5 billion by 2036: Future Market Insights forecasts a 7.5% CAGR, driven by personalised nutrition, healthy ageing, and GLP-1 nutrient-gap demand.
Top Stories
The supplement industry enters a period of potentially transformative regulatory change. Industry lawyer Ivan Wasserman stated at Probiota 2026 that this year could represent the most significant regulatory shift for dietary supplements since the introduction of Good Manufacturing Practices (GMPs). Key developments include the FDA's moves to close the self-GRAS "loophole," plans to finalise the long-awaited New Dietary Ingredient (NDI) guidance, and broader modernisation of supplement regulations [1]. These changes could fundamentally alter how new ingredients are brought to market and how supplements are regulated in the United States.
Reinforcing this trajectory, the FDA announced a public meeting scheduled for March 27, 2026, to discuss innovation in the dietary supplement industry. The meeting will explore the scope of dietary ingredients as defined under the Dietary Supplement Health and Education Act (DSHEA) of 1994, covering topics such as the definition of "dietary substance," new production methodologies, and specific ingredient types including proteins, enzymes, and microbials [2]. This initiative signals the FDA's commitment to modernising its regulatory framework while balancing innovation with consumer safety.
In a major strategic move, botanical experts MartinBauer, Finzelberg, and MB-Med have united under a single nutraceutical unit, positioning themselves as a "single gateway to the world of botanicals." The new unit integrates research, formulation expertise, and analytical precision to offer brands a streamlined route to science-driven botanical innovation. Anina Krey, global director of the unit, noted that harmonised planning shortens lead times, regional manufacturing hubs offer flexible capacity, and vertical integration provides predictable supply even in unstable market conditions [3].
Business and Investment
The supplement industry's M&A landscape remains active as companies pursue strategic consolidation. PK Consumer Health, a portfolio company of Avista Healthcare Partners and Damier Group, announced the acquisition of HealthAid, a leading UK-based vitamin, mineral, and supplement (VMS) company. The deal forms part of PK's strategy to establish itself as a leading "retail-first" VMS platform across Europe, signalling continued investor confidence in the European supplement market [4].
Separately, Monterey Bay Herb Co. completed its acquisition of NP Nutra, a premier supplier of specialty nutraceutical ingredients and botanical extracts. The combined entity now offers more than 1,000 products across herbs, botanicals, and extracts, serving customers in the nutraceuticals, food and beverage, and personal care sectors. The acquisition, backed by private equity firm Frontenac, represents Monterey Bay's second transaction and significantly strengthens its position in the nutraceutical ingredient supply chain [5].
The MartinBauer consolidation also carries significant business implications. Industry analyst Nick Stene of Euromonitor compared the move to previous consolidations such as IFF-DuPont Nutrition (2021) and DSM-Firmenich (2023), noting that MartinBauer is "sharpening their value proposition as a partner for botanical innovation." Lumina Intelligence data revealed that 69% of consumers would pay more for longevity supplements backed by clinical trials, underscoring the commercial value of science-driven positioning [3].
Science and Research
A landmark clinical trial from UC San Diego has demonstrated that a natural fungal supplement can meaningfully improve COVID-19 vaccine response. The randomised, double-blind study, published in BMC Immunology on March 3, found that a four-day course of a dual-mycelium blend derived from Agarikon (Fomitopsis officinalis) and Turkey Tail (Trametes versicolor) reduced short-term vaccine side effects while potentially tripling antibody levels for up to six months in previously unexposed individuals [6]. The findings suggest that mushroom-derived supplements could become a valuable tool in future pandemic preparedness strategies. For those interested in the broader benefits of functional mushrooms and probiotics, our Multispore Probiotic Complex combines multiple spore-forming strains to support gut health and immune function.
In the longevity space, a clinical trial examining NOVOS Core, a multi-ingredient supplement, reported improvements in markers of vascular ageing. The study, available as a pre-print on SSRN, found that the supplement improved endothelial function, arterial flexibility, and systolic blood pressure in participants over 40 [7]. While the results are promising, the non-peer-reviewed status of the study warrants cautious interpretation.
A comprehensive evidence review has provided strong validation for collagen supplementation. Researchers analysed data from 16 prior systematic reviews encompassing 113 clinical trials and nearly 8,000 patients, concluding that collagen supplements consistently improve skin elasticity and hydration while significantly reducing pain and stiffness associated with osteoarthritis. The review, published in the Aesthetic Surgery Journal Open Forum, represents one of the most thorough assessments of collagen efficacy to date [8].
New Product Launches and Formulation
Swiss online retailer IntroDrink has expanded its nutrition portfolio with a new line of nine specialised mineral formulations. The range includes highly bioavailable magnesium citrate, ionic zinc and selenium drops, and a comprehensive mineral complex, all subjected to rigorous laboratory testing to ensure purity and potency [9]. The launch reflects growing consumer demand for bioavailable, science-backed mineral supplementation.
The rapidly expanding adoption of GLP-1 receptor agonists for weight management is creating a significant new product category for the supplement industry. As these medications reduce caloric intake, demand is surging for protein, fibre, and micronutrient products designed to address the resulting nutritional gaps. Future Market Insights projects that over 30 million North Americans will use GLP-1 drugs by 2030, representing a substantial addressable market for targeted nutrient-gap formulations [10]. Adaptogens such as Ashwagandha KSM-66 are also gaining attention for their role in supporting metabolic balance and stress resilience during weight management programmes.
Meanwhile, the mainstream adoption of upcycled ingredients in supplements and functional foods continues to face headwinds. A new analysis from Fi Global Insights identifies higher production costs, limited consumer understanding of the "upcycled" concept, and negative associations with waste as key barriers to broader market penetration [11]. Despite growing sustainability awareness, brands may need to invest significantly in consumer education before upcycled ingredients gain meaningful traction.
Regulations and Quality
A large-scale EU customs control operation has exposed widespread non-compliance among food supplements sold online from outside the European Union. The operation, conducted in cooperation with Market Surveillance Authorities and Food Safety Authorities, checked nearly 3,500 food supplement products and found that the majority failed to meet EU standards. Common issues included incorrect or missing labelling, absence of necessary documentation, and the presence of forbidden ingredients. The United States, China, and the United Kingdom were identified as the leading sources of non-compliant products [12]. Since 2022, the volume of small parcels entering the EU has doubled annually, reaching 5.8 billion packages in 2025.
In the United States, a chocolate male enhancement supplement branded as Rhino Choco VIP 10X has been recalled due to the presence of undeclared tadalafil, the active ingredient in the prescription medication Cialis. The undeclared pharmaceutical ingredient poses serious health risks for consumers with cardiovascular conditions or those taking nitrate-based medications [13]. The recall underscores the ongoing challenge of adulterated supplements in the marketplace.
The supplement industry is also witnessing a proactive shift toward enhanced safety standards. NOW Foods has hired a dedicated toxicologist to conduct comprehensive safety assessments of all ingredients, going beyond minimum regulatory requirements to establish safe upper intake limits and investigate potential long-term risks [14]. This approach may set a new benchmark for the industry as regulatory scrutiny intensifies. Anti-inflammatory ingredients like organic curcumin continue to benefit from this trend toward evidence-based supplementation, with curcumin's extensive clinical research base providing the kind of transparency consumers increasingly demand.
Marketing and Consumer Trends
The supplement market is undergoing a generational shift as younger consumers, particularly Gen Z, increasingly view wellness as a form of self-expression. This trend is driving a "premiumisation" of the market, with greater emphasis on aesthetically pleasing packaging and benefit-focused branding that resonates with lifestyle-oriented audiences. The convergence of beauty, wellness, and nutrition is creating new market opportunities for brands that can authentically bridge these categories [15].
Consumer demand for sustainable, eco-friendly, and vegan products is reshaping the omega-3 supplement market. While soft gels have traditionally dominated, capsule formats are gaining popularity as consumers seek plant-based alternatives. This shift reflects a broader movement toward conscious consumption and signals opportunities for brands offering algae-derived or other vegan omega-3 formulations [16].
The plant-based performance nutrition segment continues to gain momentum, driven by growing consumer demand for clean, sustainable, and athlete-friendly nutrition. Companies across the industry are reformulating and rebranding products to cater to this demand, with a particular focus on plant-based ingredients that support athletic performance, endurance, and recovery [17].
Supply Chain and Manufacturing
The North American dietary supplements market is on a strong growth trajectory, projected to expand from $79.2 billion in 2025 to $175.5 billion by 2036, representing a 7.5% compound annual growth rate. Key growth drivers include personalised nutrition, healthy ageing demographics, and the emerging demand for supplements that address nutritional gaps created by GLP-1 weight management drugs [10]. However, the report identifies raw material costs, particularly for vitamins sourced from China, as a key margin risk for manufacturers.
MartinBauer's new nutraceutical unit addresses supply chain resilience directly. Euromonitor's Nick Stene noted that brands have spent recent years battling shortages, trade barriers, and logistics bottlenecks, and that "with global supply chains facing fresh disruption in March 2026, that pain is back at the top of the agenda." MartinBauer's multi-regional manufacturing footprint offers improved defence in depth, even if it cannot solve every geopolitical choke point [3].
Chinese supplier Shaanxi Yuantai Biological Technology (YTBIO) has highlighted its cGMP certification as a cornerstone of quality commitment, emphasising rigorous control over raw materials, contamination prevention, and standardised manufacturing processes. The company's integrated approach, combining raw material expertise with finished product manufacturing, aims to provide reliable supplement solutions to the global market [18].
International Markets
The European Commission's customs operation findings carry significant implications for cross-border supplement trade. With the majority of online-sold supplements from third countries failing EU compliance checks, brands exporting to Europe face heightened scrutiny. The operation revealed that non-compliance is pervasive across the entire online food supplement market, not limited to specific platforms or sellers [12].
The global dietary supplements market is expected to reach $220 billion in 2025, with 28% of growth attributed to cross-border e-commerce sales. This expansion is accompanied by significant regulatory changes, including the potential end of the de minimis threshold in the United States and the implementation of 12-digit HS codes in GCC countries, which will require greater precision in customs classification for supplement brands operating internationally [19].
E-commerce growth continues to reshape international supplement distribution, but regulatory harmonisation remains a challenge. Brands seeking to operate across multiple markets must navigate an increasingly complex web of labelling requirements, ingredient restrictions, and customs procedures. The EU findings suggest that proactive compliance investment is no longer optional for brands with international ambitions.
References
- NutraIngredients: Could 2026 be the biggest year for dietary supplements since the introduction of GMPs?
- FDA.gov: FDA Announces Public Meeting on Dietary Supplement Innovation and Scope of Dietary Ingredients
- NutraIngredients: MartinBauer nutraceutical unit delivers 'single gateway to the world of botanicals'
- PR Newswire: PK Consumer Health Announces the Acquisition of HealthAid
- PR Newswire: Monterey Bay Herb Co. Acquires NP Nutra, Expanding Leadership in Nutraceutical Ingredients
- UC San Diego Today: Study Finds Natural Fungal Supplement Improves COVID-19 Vaccine Response
- Medical News Today: Longevity Supplement Improves Vascular Aging Markers in Clinical Trial
- HealthDay: Collagen Supplements Good For Skin, Arthritis, Evidence Review Concludes
- Bluffton Today: IntroDrink Expands Swiss Nutrition Portfolio with Enhanced Mineral Supplement Range
- Yahoo Finance / FMI: North American Dietary Supplements Market Poised to Add USD 90.4B by 2036
- Fi Global Insights: Cost and Consumer Trust Barriers Limit Upcycled Ingredient Adoption
- European Commission: Large Scale EU Customs Control Action Shows Most Third-Country E-Commerce Goods Do Not Follow Standards
- USA Today: Company Recalls Chocolate Male Enhancement Supplement
- NutraIngredients: Why NOW Employs a Toxicologist to Strengthen Dietary Supplement Safety
- Love Life Supplements: Supplement Industry Daily Briefing March 3, 2026
- Nutrition Insight: Omega-3 Supplement Market Trends
- EIN Presswire: Nutritional Supplements Market 2026 — Capture Growth Opportunities in the Expanding Wellness Economy
- Milwaukee Journal Sentinel: cGMP Certified — The Standard of Excellence Maintained by a Key Chinese Dietary Supplement Supplier
- FreightAmigo: HS Code for Retail Packed Food Supplements
About the Author
Ben Law is the founder of Love Life Supplements, a UK-based supplement company committed to providing premium, science-backed nutritional products. With a passion for health optimisation and a deep understanding of the supplement industry, Ben curates this daily briefing to keep industry professionals informed about the latest developments shaping the nutraceutical landscape. His mission is to make high-quality supplementation accessible while maintaining the highest standards of transparency and scientific integrity.

